Submitted by Anonymous (not verified) on 8 May 2025 - 8:40
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 11, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 11, Status: Authorised